nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—systemic scleroderma—Esomeprazole—Barrett's esophagus	0.243	0.5	CpDpCtD
Meloxicam—systemic scleroderma—Omeprazole—Barrett's esophagus	0.243	0.5	CpDpCtD
Meloxicam—PTGS2—Barrett's esophagus	0.234	1	CbGaD
Meloxicam—CYP2C8—Omeprazole—Barrett's esophagus	0.0595	0.358	CbGbCtD
Meloxicam—CYP2C9—Omeprazole—Barrett's esophagus	0.0415	0.25	CbGbCtD
Meloxicam—CYP3A4—Esomeprazole—Barrett's esophagus	0.0409	0.247	CbGbCtD
Meloxicam—CYP3A4—Omeprazole—Barrett's esophagus	0.0241	0.145	CbGbCtD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00142	0.0894	CbGpPWpGaD
Meloxicam—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00131	0.0823	CbGpPWpGaD
Meloxicam—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00113	0.071	CbGpPWpGaD
Meloxicam—Lornoxicam—PTGS2—Barrett's esophagus	0.000947	0.41	CrCbGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.000926	0.0581	CbGpPWpGaD
Meloxicam—Tenoxicam—PTGS2—Barrett's esophagus	0.000844	0.365	CrCbGaD
Meloxicam—PTGS2—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.000735	0.0461	CbGpPWpGaD
Meloxicam—Oesophagitis—Omeprazole—Barrett's esophagus	0.000555	0.0058	CcSEcCtD
Meloxicam—Oesophagitis—Esomeprazole—Barrett's esophagus	0.000555	0.0058	CcSEcCtD
Meloxicam—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.000552	0.00576	CcSEcCtD
Meloxicam—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.000552	0.00576	CcSEcCtD
Meloxicam—Mouth ulceration—Omeprazole—Barrett's esophagus	0.000549	0.00573	CcSEcCtD
Meloxicam—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.000549	0.00573	CcSEcCtD
Meloxicam—Lightheadedness—Esomeprazole—Barrett's esophagus	0.000544	0.00567	CcSEcCtD
Meloxicam—Lightheadedness—Omeprazole—Barrett's esophagus	0.000544	0.00567	CcSEcCtD
Meloxicam—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00053	0.00553	CcSEcCtD
Meloxicam—Abnormal vision—Omeprazole—Barrett's esophagus	0.00053	0.00553	CcSEcCtD
Meloxicam—Piroxicam—PTGS2—Barrett's esophagus	0.000522	0.226	CrCbGaD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000514	0.0323	CbGpPWpGaD
Meloxicam—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.000505	0.00527	CcSEcCtD
Meloxicam—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.000505	0.00527	CcSEcCtD
Meloxicam—Photosensitivity—Omeprazole—Barrett's esophagus	0.000502	0.00524	CcSEcCtD
Meloxicam—Photosensitivity—Esomeprazole—Barrett's esophagus	0.000502	0.00524	CcSEcCtD
Meloxicam—Swelling—Esomeprazole—Barrett's esophagus	0.0005	0.00522	CcSEcCtD
Meloxicam—Swelling—Omeprazole—Barrett's esophagus	0.0005	0.00522	CcSEcCtD
Meloxicam—Vascular purpura—Omeprazole—Barrett's esophagus	0.000493	0.00515	CcSEcCtD
Meloxicam—Vascular purpura—Esomeprazole—Barrett's esophagus	0.000493	0.00515	CcSEcCtD
Meloxicam—Hepatic failure—Esomeprazole—Barrett's esophagus	0.000491	0.00512	CcSEcCtD
Meloxicam—Hepatic failure—Omeprazole—Barrett's esophagus	0.000491	0.00512	CcSEcCtD
Meloxicam—Hot flush—Esomeprazole—Barrett's esophagus	0.000472	0.00492	CcSEcCtD
Meloxicam—Hot flush—Omeprazole—Barrett's esophagus	0.000472	0.00492	CcSEcCtD
Meloxicam—Increased appetite—Esomeprazole—Barrett's esophagus	0.00047	0.0049	CcSEcCtD
Meloxicam—Increased appetite—Omeprazole—Barrett's esophagus	0.00047	0.0049	CcSEcCtD
Meloxicam—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.000468	0.00488	CcSEcCtD
Meloxicam—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.000468	0.00488	CcSEcCtD
Meloxicam—Visual disturbance—Esomeprazole—Barrett's esophagus	0.000466	0.00486	CcSEcCtD
Meloxicam—Visual disturbance—Omeprazole—Barrett's esophagus	0.000466	0.00486	CcSEcCtD
Meloxicam—Renal impairment—Esomeprazole—Barrett's esophagus	0.000464	0.00484	CcSEcCtD
Meloxicam—Renal impairment—Omeprazole—Barrett's esophagus	0.000464	0.00484	CcSEcCtD
Meloxicam—Purpura—Omeprazole—Barrett's esophagus	0.000458	0.00478	CcSEcCtD
Meloxicam—Purpura—Esomeprazole—Barrett's esophagus	0.000458	0.00478	CcSEcCtD
Meloxicam—Arthritis—Omeprazole—Barrett's esophagus	0.000454	0.00474	CcSEcCtD
Meloxicam—Arthritis—Esomeprazole—Barrett's esophagus	0.000454	0.00474	CcSEcCtD
Meloxicam—Pain in extremity—Omeprazole—Barrett's esophagus	0.000441	0.0046	CcSEcCtD
Meloxicam—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000441	0.0046	CcSEcCtD
Meloxicam—Pain in extremity—Esomeprazole—Barrett's esophagus	0.000441	0.0046	CcSEcCtD
Meloxicam—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000441	0.0046	CcSEcCtD
Meloxicam—Face oedema—Omeprazole—Barrett's esophagus	0.000426	0.00444	CcSEcCtD
Meloxicam—Face oedema—Esomeprazole—Barrett's esophagus	0.000426	0.00444	CcSEcCtD
Meloxicam—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000413	0.00431	CcSEcCtD
Meloxicam—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000413	0.00431	CcSEcCtD
Meloxicam—PTGS2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000408	0.0256	CbGpPWpGaD
Meloxicam—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000403	0.0042	CcSEcCtD
Meloxicam—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000403	0.0042	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000397	0.00415	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000397	0.00415	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000397	0.00415	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000397	0.00415	CcSEcCtD
Meloxicam—Gastritis—Esomeprazole—Barrett's esophagus	0.00039	0.00407	CcSEcCtD
Meloxicam—Gastritis—Omeprazole—Barrett's esophagus	0.00039	0.00407	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000389	0.00406	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000389	0.00406	CcSEcCtD
Meloxicam—Influenza—Omeprazole—Barrett's esophagus	0.000381	0.00398	CcSEcCtD
Meloxicam—Asthma—Omeprazole—Barrett's esophagus	0.000381	0.00398	CcSEcCtD
Meloxicam—Asthma—Esomeprazole—Barrett's esophagus	0.000381	0.00398	CcSEcCtD
Meloxicam—Influenza—Esomeprazole—Barrett's esophagus	0.000381	0.00398	CcSEcCtD
Meloxicam—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000375	0.00391	CcSEcCtD
Meloxicam—Bronchospasm—Omeprazole—Barrett's esophagus	0.000375	0.00391	CcSEcCtD
Meloxicam—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000374	0.0039	CcSEcCtD
Meloxicam—Pancreatitis—Omeprazole—Barrett's esophagus	0.000374	0.0039	CcSEcCtD
Meloxicam—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000371	0.00388	CcSEcCtD
Meloxicam—Sweating increased—Esomeprazole—Barrett's esophagus	0.000371	0.00388	CcSEcCtD
Meloxicam—Angina pectoris—Omeprazole—Barrett's esophagus	0.000371	0.00388	CcSEcCtD
Meloxicam—Sweating increased—Omeprazole—Barrett's esophagus	0.000371	0.00388	CcSEcCtD
Meloxicam—Pancytopenia—Omeprazole—Barrett's esophagus	0.000362	0.00378	CcSEcCtD
Meloxicam—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000362	0.00378	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000354	0.0037	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000354	0.0037	CcSEcCtD
Meloxicam—Pollakiuria—Omeprazole—Barrett's esophagus	0.000352	0.00368	CcSEcCtD
Meloxicam—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000352	0.00368	CcSEcCtD
Meloxicam—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000348	0.00363	CcSEcCtD
Meloxicam—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000348	0.00363	CcSEcCtD
Meloxicam—Weight increased—Esomeprazole—Barrett's esophagus	0.000347	0.00362	CcSEcCtD
Meloxicam—Weight increased—Omeprazole—Barrett's esophagus	0.000347	0.00362	CcSEcCtD
Meloxicam—Weight decreased—Esomeprazole—Barrett's esophagus	0.000345	0.0036	CcSEcCtD
Meloxicam—Weight decreased—Omeprazole—Barrett's esophagus	0.000345	0.0036	CcSEcCtD
Meloxicam—Infestation NOS—Omeprazole—Barrett's esophagus	0.00034	0.00355	CcSEcCtD
Meloxicam—Infestation—Omeprazole—Barrett's esophagus	0.00034	0.00355	CcSEcCtD
Meloxicam—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00034	0.00355	CcSEcCtD
Meloxicam—Infestation—Esomeprazole—Barrett's esophagus	0.00034	0.00355	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000337	0.00352	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000337	0.00352	CcSEcCtD
Meloxicam—Renal failure—Omeprazole—Barrett's esophagus	0.000334	0.00349	CcSEcCtD
Meloxicam—Renal failure—Esomeprazole—Barrett's esophagus	0.000334	0.00349	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000332	0.0209	CbGpPWpGaD
Meloxicam—Jaundice—Esomeprazole—Barrett's esophagus	0.000331	0.00346	CcSEcCtD
Meloxicam—Stomatitis—Esomeprazole—Barrett's esophagus	0.000331	0.00346	CcSEcCtD
Meloxicam—Jaundice—Omeprazole—Barrett's esophagus	0.000331	0.00346	CcSEcCtD
Meloxicam—Stomatitis—Omeprazole—Barrett's esophagus	0.000331	0.00346	CcSEcCtD
Meloxicam—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00033	0.00345	CcSEcCtD
Meloxicam—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00033	0.00345	CcSEcCtD
Meloxicam—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00033	0.00345	CcSEcCtD
Meloxicam—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00033	0.00345	CcSEcCtD
Meloxicam—Haematuria—Esomeprazole—Barrett's esophagus	0.000324	0.00338	CcSEcCtD
Meloxicam—Haematuria—Omeprazole—Barrett's esophagus	0.000324	0.00338	CcSEcCtD
Meloxicam—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000322	0.00336	CcSEcCtD
Meloxicam—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000322	0.00336	CcSEcCtD
Meloxicam—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00032	0.0201	CbGpPWpGaD
Meloxicam—Sinusitis—Esomeprazole—Barrett's esophagus	0.000319	0.00333	CcSEcCtD
Meloxicam—Sinusitis—Omeprazole—Barrett's esophagus	0.000319	0.00333	CcSEcCtD
Meloxicam—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000317	0.00331	CcSEcCtD
Meloxicam—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000317	0.00331	CcSEcCtD
Meloxicam—Rhinitis—Omeprazole—Barrett's esophagus	0.000306	0.00319	CcSEcCtD
Meloxicam—Rhinitis—Esomeprazole—Barrett's esophagus	0.000306	0.00319	CcSEcCtD
Meloxicam—Hepatitis—Esomeprazole—Barrett's esophagus	0.000305	0.00318	CcSEcCtD
Meloxicam—Hepatitis—Omeprazole—Barrett's esophagus	0.000305	0.00318	CcSEcCtD
Meloxicam—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000303	0.00316	CcSEcCtD
Meloxicam—Pharyngitis—Omeprazole—Barrett's esophagus	0.000303	0.00316	CcSEcCtD
Meloxicam—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000301	0.00315	CcSEcCtD
Meloxicam—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000301	0.00315	CcSEcCtD
Meloxicam—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000301	0.00314	CcSEcCtD
Meloxicam—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000301	0.00314	CcSEcCtD
Meloxicam—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.0003	0.00313	CcSEcCtD
Meloxicam—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.0003	0.00313	CcSEcCtD
Meloxicam—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000299	0.00312	CcSEcCtD
Meloxicam—Urethral disorder—Omeprazole—Barrett's esophagus	0.000299	0.00312	CcSEcCtD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.000297	0.0186	CbGpPWpGaD
Meloxicam—Visual impairment—Omeprazole—Barrett's esophagus	0.000294	0.00307	CcSEcCtD
Meloxicam—Visual impairment—Esomeprazole—Barrett's esophagus	0.000294	0.00307	CcSEcCtD
Meloxicam—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000289	0.00301	CcSEcCtD
Meloxicam—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000289	0.00301	CcSEcCtD
Meloxicam—Eye disorder—Esomeprazole—Barrett's esophagus	0.000285	0.00298	CcSEcCtD
Meloxicam—Eye disorder—Omeprazole—Barrett's esophagus	0.000285	0.00298	CcSEcCtD
Meloxicam—Tinnitus—Omeprazole—Barrett's esophagus	0.000285	0.00297	CcSEcCtD
Meloxicam—Tinnitus—Esomeprazole—Barrett's esophagus	0.000285	0.00297	CcSEcCtD
Meloxicam—Flushing—Esomeprazole—Barrett's esophagus	0.000283	0.00296	CcSEcCtD
Meloxicam—Flushing—Omeprazole—Barrett's esophagus	0.000283	0.00296	CcSEcCtD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Barrett's esophagus	0.000279	0.0175	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000279	0.0175	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000279	0.0175	CbGpPWpGaD
Meloxicam—Immune system disorder—Omeprazole—Barrett's esophagus	0.000276	0.00288	CcSEcCtD
Meloxicam—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000276	0.00288	CcSEcCtD
Meloxicam—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000275	0.00287	CcSEcCtD
Meloxicam—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000275	0.00287	CcSEcCtD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000273	0.0171	CbGpPWpGaD
Meloxicam—PGD—NRF2 pathway—HGF—Barrett's esophagus	0.000271	0.017	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00027	0.017	CbGpPWpGaD
Meloxicam—Alopecia—Esomeprazole—Barrett's esophagus	0.00027	0.00281	CcSEcCtD
Meloxicam—Alopecia—Omeprazole—Barrett's esophagus	0.00027	0.00281	CcSEcCtD
Meloxicam—PGD—Carbohydrate metabolism—SLC9A1—Barrett's esophagus	0.000269	0.0169	CbGpPWpGaD
Meloxicam—Mental disorder—Esomeprazole—Barrett's esophagus	0.000267	0.00279	CcSEcCtD
Meloxicam—Mental disorder—Omeprazole—Barrett's esophagus	0.000267	0.00279	CcSEcCtD
Meloxicam—Malnutrition—Omeprazole—Barrett's esophagus	0.000266	0.00277	CcSEcCtD
Meloxicam—Malnutrition—Esomeprazole—Barrett's esophagus	0.000266	0.00277	CcSEcCtD
Meloxicam—Flatulence—Esomeprazole—Barrett's esophagus	0.000262	0.00273	CcSEcCtD
Meloxicam—Flatulence—Omeprazole—Barrett's esophagus	0.000262	0.00273	CcSEcCtD
Meloxicam—Tension—Omeprazole—Barrett's esophagus	0.000261	0.00272	CcSEcCtD
Meloxicam—Tension—Esomeprazole—Barrett's esophagus	0.000261	0.00272	CcSEcCtD
Meloxicam—Dysgeusia—Omeprazole—Barrett's esophagus	0.00026	0.00271	CcSEcCtD
Meloxicam—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00026	0.00271	CcSEcCtD
Meloxicam—Nervousness—Omeprazole—Barrett's esophagus	0.000258	0.00269	CcSEcCtD
Meloxicam—Nervousness—Esomeprazole—Barrett's esophagus	0.000258	0.00269	CcSEcCtD
Meloxicam—Back pain—Omeprazole—Barrett's esophagus	0.000257	0.00268	CcSEcCtD
Meloxicam—Back pain—Esomeprazole—Barrett's esophagus	0.000257	0.00268	CcSEcCtD
Meloxicam—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000255	0.00267	CcSEcCtD
Meloxicam—Muscle spasms—Omeprazole—Barrett's esophagus	0.000255	0.00267	CcSEcCtD
Meloxicam—Vision blurred—Omeprazole—Barrett's esophagus	0.00025	0.00261	CcSEcCtD
Meloxicam—Vision blurred—Esomeprazole—Barrett's esophagus	0.00025	0.00261	CcSEcCtD
Meloxicam—Tremor—Omeprazole—Barrett's esophagus	0.000249	0.0026	CcSEcCtD
Meloxicam—Tremor—Esomeprazole—Barrett's esophagus	0.000249	0.0026	CcSEcCtD
Meloxicam—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000247	0.00257	CcSEcCtD
Meloxicam—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000247	0.00257	CcSEcCtD
Meloxicam—Anaemia—Omeprazole—Barrett's esophagus	0.000246	0.00256	CcSEcCtD
Meloxicam—Anaemia—Esomeprazole—Barrett's esophagus	0.000246	0.00256	CcSEcCtD
Meloxicam—Angioedema—Esomeprazole—Barrett's esophagus	0.000243	0.00253	CcSEcCtD
Meloxicam—Angioedema—Omeprazole—Barrett's esophagus	0.000243	0.00253	CcSEcCtD
Meloxicam—Malaise—Esomeprazole—Barrett's esophagus	0.00024	0.0025	CcSEcCtD
Meloxicam—Malaise—Omeprazole—Barrett's esophagus	0.00024	0.0025	CcSEcCtD
Meloxicam—Vertigo—Omeprazole—Barrett's esophagus	0.000239	0.00249	CcSEcCtD
Meloxicam—Vertigo—Esomeprazole—Barrett's esophagus	0.000239	0.00249	CcSEcCtD
Meloxicam—Leukopenia—Esomeprazole—Barrett's esophagus	0.000238	0.00248	CcSEcCtD
Meloxicam—Leukopenia—Omeprazole—Barrett's esophagus	0.000238	0.00248	CcSEcCtD
Meloxicam—Palpitations—Esomeprazole—Barrett's esophagus	0.000235	0.00245	CcSEcCtD
Meloxicam—Palpitations—Omeprazole—Barrett's esophagus	0.000235	0.00245	CcSEcCtD
Meloxicam—Cough—Esomeprazole—Barrett's esophagus	0.000232	0.00242	CcSEcCtD
Meloxicam—Cough—Omeprazole—Barrett's esophagus	0.000232	0.00242	CcSEcCtD
Meloxicam—Hypertension—Esomeprazole—Barrett's esophagus	0.000229	0.00239	CcSEcCtD
Meloxicam—Hypertension—Omeprazole—Barrett's esophagus	0.000229	0.00239	CcSEcCtD
Meloxicam—Myalgia—Esomeprazole—Barrett's esophagus	0.000226	0.00236	CcSEcCtD
Meloxicam—Myalgia—Omeprazole—Barrett's esophagus	0.000226	0.00236	CcSEcCtD
Meloxicam—Arthralgia—Omeprazole—Barrett's esophagus	0.000226	0.00236	CcSEcCtD
Meloxicam—Arthralgia—Esomeprazole—Barrett's esophagus	0.000226	0.00236	CcSEcCtD
Meloxicam—Anxiety—Omeprazole—Barrett's esophagus	0.000225	0.00235	CcSEcCtD
Meloxicam—Anxiety—Esomeprazole—Barrett's esophagus	0.000225	0.00235	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000225	0.00234	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000225	0.00234	CcSEcCtD
Meloxicam—Discomfort—Esomeprazole—Barrett's esophagus	0.000223	0.00233	CcSEcCtD
Meloxicam—Discomfort—Omeprazole—Barrett's esophagus	0.000223	0.00233	CcSEcCtD
Meloxicam—Dry mouth—Omeprazole—Barrett's esophagus	0.000221	0.00231	CcSEcCtD
Meloxicam—Dry mouth—Esomeprazole—Barrett's esophagus	0.000221	0.00231	CcSEcCtD
Meloxicam—PTGS1—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.000219	0.0137	CbGpPWpGaD
Meloxicam—Confusional state—Esomeprazole—Barrett's esophagus	0.000219	0.00228	CcSEcCtD
Meloxicam—Confusional state—Omeprazole—Barrett's esophagus	0.000219	0.00228	CcSEcCtD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000218	0.0137	CbGpPWpGaD
Meloxicam—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000217	0.00226	CcSEcCtD
Meloxicam—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000217	0.00226	CcSEcCtD
Meloxicam—Infection—Omeprazole—Barrett's esophagus	0.000215	0.00225	CcSEcCtD
Meloxicam—Infection—Esomeprazole—Barrett's esophagus	0.000215	0.00225	CcSEcCtD
Meloxicam—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000215	0.0135	CbGpPWpGaD
Meloxicam—Shock—Esomeprazole—Barrett's esophagus	0.000213	0.00223	CcSEcCtD
Meloxicam—Shock—Omeprazole—Barrett's esophagus	0.000213	0.00223	CcSEcCtD
Meloxicam—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000213	0.00222	CcSEcCtD
Meloxicam—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000213	0.00222	CcSEcCtD
Meloxicam—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000212	0.00222	CcSEcCtD
Meloxicam—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000212	0.00222	CcSEcCtD
Meloxicam—PTGS1—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000212	0.0133	CbGpPWpGaD
Meloxicam—Tachycardia—Omeprazole—Barrett's esophagus	0.000212	0.00221	CcSEcCtD
Meloxicam—Tachycardia—Esomeprazole—Barrett's esophagus	0.000212	0.00221	CcSEcCtD
Meloxicam—Skin disorder—Esomeprazole—Barrett's esophagus	0.000211	0.0022	CcSEcCtD
Meloxicam—Skin disorder—Omeprazole—Barrett's esophagus	0.000211	0.0022	CcSEcCtD
Meloxicam—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00021	0.00219	CcSEcCtD
Meloxicam—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00021	0.00219	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000198	0.00206	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000198	0.00206	CcSEcCtD
Meloxicam—Insomnia—Esomeprazole—Barrett's esophagus	0.000196	0.00205	CcSEcCtD
Meloxicam—Insomnia—Omeprazole—Barrett's esophagus	0.000196	0.00205	CcSEcCtD
Meloxicam—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000195	0.00203	CcSEcCtD
Meloxicam—Paraesthesia—Omeprazole—Barrett's esophagus	0.000195	0.00203	CcSEcCtD
Meloxicam—Dyspnoea—Omeprazole—Barrett's esophagus	0.000193	0.00202	CcSEcCtD
Meloxicam—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000193	0.00202	CcSEcCtD
Meloxicam—Somnolence—Omeprazole—Barrett's esophagus	0.000193	0.00201	CcSEcCtD
Meloxicam—Somnolence—Esomeprazole—Barrett's esophagus	0.000193	0.00201	CcSEcCtD
Meloxicam—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000191	0.00199	CcSEcCtD
Meloxicam—Dyspepsia—Omeprazole—Barrett's esophagus	0.000191	0.00199	CcSEcCtD
Meloxicam—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000188	0.00197	CcSEcCtD
Meloxicam—Decreased appetite—Omeprazole—Barrett's esophagus	0.000188	0.00197	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000187	0.00195	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000187	0.00195	CcSEcCtD
Meloxicam—Fatigue—Esomeprazole—Barrett's esophagus	0.000187	0.00195	CcSEcCtD
Meloxicam—Fatigue—Omeprazole—Barrett's esophagus	0.000187	0.00195	CcSEcCtD
Meloxicam—ABCC4—Ectoderm Differentiation—BMP4—Barrett's esophagus	0.000186	0.0117	CbGpPWpGaD
Meloxicam—Constipation—Omeprazole—Barrett's esophagus	0.000185	0.00193	CcSEcCtD
Meloxicam—Pain—Esomeprazole—Barrett's esophagus	0.000185	0.00193	CcSEcCtD
Meloxicam—Pain—Omeprazole—Barrett's esophagus	0.000185	0.00193	CcSEcCtD
Meloxicam—Constipation—Esomeprazole—Barrett's esophagus	0.000185	0.00193	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000184	0.0116	CbGpPWpGaD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000184	0.0116	CbGpPWpGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000182	0.0114	CbGpPWpGaD
Meloxicam—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000179	0.00186	CcSEcCtD
Meloxicam—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000179	0.00186	CcSEcCtD
Meloxicam—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000177	0.00185	CcSEcCtD
Meloxicam—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000177	0.00185	CcSEcCtD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000177	0.0111	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000176	0.0111	CbGpPWpGaD
Meloxicam—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000175	0.011	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—HGF—Barrett's esophagus	0.000174	0.011	CbGpPWpGaD
Meloxicam—Urticaria—Omeprazole—Barrett's esophagus	0.000172	0.0018	CcSEcCtD
Meloxicam—Urticaria—Esomeprazole—Barrett's esophagus	0.000172	0.0018	CcSEcCtD
Meloxicam—Abdominal pain—Omeprazole—Barrett's esophagus	0.000171	0.00179	CcSEcCtD
Meloxicam—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000171	0.00179	CcSEcCtD
Meloxicam—Body temperature increased—Omeprazole—Barrett's esophagus	0.000171	0.00179	CcSEcCtD
Meloxicam—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000171	0.00179	CcSEcCtD
Meloxicam—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000169	0.0106	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000166	0.0104	CbGpPWpGaD
Meloxicam—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00016	0.00167	CcSEcCtD
Meloxicam—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00016	0.00167	CcSEcCtD
Meloxicam—Asthenia—Omeprazole—Barrett's esophagus	0.000156	0.00162	CcSEcCtD
Meloxicam—Asthenia—Esomeprazole—Barrett's esophagus	0.000156	0.00162	CcSEcCtD
Meloxicam—Pruritus—Esomeprazole—Barrett's esophagus	0.000153	0.0016	CcSEcCtD
Meloxicam—Pruritus—Omeprazole—Barrett's esophagus	0.000153	0.0016	CcSEcCtD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000152	0.00953	CbGpPWpGaD
Meloxicam—Diarrhoea—Omeprazole—Barrett's esophagus	0.000148	0.00155	CcSEcCtD
Meloxicam—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000148	0.00155	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000145	0.00911	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000144	0.00902	CbGpPWpGaD
Meloxicam—Dizziness—Omeprazole—Barrett's esophagus	0.000143	0.0015	CcSEcCtD
Meloxicam—Dizziness—Esomeprazole—Barrett's esophagus	0.000143	0.0015	CcSEcCtD
Meloxicam—Vomiting—Omeprazole—Barrett's esophagus	0.000138	0.00144	CcSEcCtD
Meloxicam—Vomiting—Esomeprazole—Barrett's esophagus	0.000138	0.00144	CcSEcCtD
Meloxicam—Rash—Omeprazole—Barrett's esophagus	0.000137	0.00143	CcSEcCtD
Meloxicam—Rash—Esomeprazole—Barrett's esophagus	0.000137	0.00143	CcSEcCtD
Meloxicam—Dermatitis—Omeprazole—Barrett's esophagus	0.000137	0.00143	CcSEcCtD
Meloxicam—Dermatitis—Esomeprazole—Barrett's esophagus	0.000137	0.00143	CcSEcCtD
Meloxicam—Headache—Esomeprazole—Barrett's esophagus	0.000136	0.00142	CcSEcCtD
Meloxicam—Headache—Omeprazole—Barrett's esophagus	0.000136	0.00142	CcSEcCtD
Meloxicam—Nausea—Esomeprazole—Barrett's esophagus	0.000129	0.00134	CcSEcCtD
Meloxicam—Nausea—Omeprazole—Barrett's esophagus	0.000129	0.00134	CcSEcCtD
Meloxicam—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000128	0.00801	CbGpPWpGaD
Meloxicam—ABCC4—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000119	0.00746	CbGpPWpGaD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000117	0.00733	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGES—Barrett's esophagus	0.000117	0.00733	CbGpPWpGaD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000115	0.00724	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—HGF—Barrett's esophagus	0.000108	0.00677	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000102	0.00639	CbGpPWpGaD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000101	0.00634	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	9.47e-05	0.00595	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	9.37e-05	0.00588	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.24e-05	0.0058	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.18e-05	0.00576	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CYP26A1—Barrett's esophagus	8.85e-05	0.00555	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.84e-05	0.00555	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	8.81e-05	0.00553	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	7.77e-05	0.00488	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	7.74e-05	0.00486	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	7.63e-05	0.00479	CbGpPWpGaD
Meloxicam—PGD—Disease—SLC9A1—Barrett's esophagus	7.62e-05	0.00478	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.52e-05	0.00472	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.35e-05	0.00462	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	6.61e-05	0.00415	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	6.52e-05	0.00409	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	6.42e-05	0.00403	CbGpPWpGaD
Meloxicam—PGD—Metabolism—SLC9A1—Barrett's esophagus	6.38e-05	0.004	CbGpPWpGaD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	6.34e-05	0.00398	CbGpPWpGaD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	6.06e-05	0.0038	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.84e-05	0.00366	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	5.66e-05	0.00355	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.42e-05	0.0034	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	5.31e-05	0.00333	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	5.25e-05	0.00329	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	5.03e-05	0.00316	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	4.96e-05	0.00311	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.75e-05	0.00298	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HGF—Barrett's esophagus	3.99e-05	0.0025	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	3.91e-05	0.00245	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	3.87e-05	0.00243	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	3.61e-05	0.00227	CbGpPWpGaD
Meloxicam—PGD—Disease—APC—Barrett's esophagus	3.6e-05	0.00226	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGES—Barrett's esophagus	3.27e-05	0.00206	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PPARG—Barrett's esophagus	2.91e-05	0.00183	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—Barrett's esophagus	2.73e-05	0.00172	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTGES—Barrett's esophagus	2.6e-05	0.00163	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	2.48e-05	0.00156	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	2.4e-05	0.00151	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—Barrett's esophagus	2.29e-05	0.00144	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGES—Barrett's esophagus	2.12e-05	0.00133	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	1.97e-05	0.00124	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.83e-05	0.00115	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	1.79e-05	0.00112	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGES—Barrett's esophagus	1.72e-05	0.00108	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC9A1—Barrett's esophagus	1.7e-05	0.00106	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.63e-05	0.00102	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	1.6e-05	0.00101	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.46e-05	0.000914	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.44e-05	0.000905	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	1.42e-05	0.000891	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—Barrett's esophagus	1.34e-05	0.00084	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	1.3e-05	0.000819	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.18e-05	0.000743	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.16e-05	0.000725	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.14e-05	0.000713	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	9.64e-06	0.000605	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	9.4e-06	0.00059	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	9.32e-06	0.000585	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	8.6e-06	0.00054	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—Barrett's esophagus	8.17e-06	0.000513	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—Barrett's esophagus	8.02e-06	0.000503	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	7.58e-06	0.000476	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—Barrett's esophagus	6.48e-06	0.000407	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—Barrett's esophagus	6.42e-06	0.000403	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	6.2e-06	0.000389	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—Barrett's esophagus	5.27e-06	0.000331	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—Barrett's esophagus	4.29e-06	0.000269	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	4.15e-06	0.00026	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	3.38e-06	0.000212	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—Barrett's esophagus	2.83e-06	0.000178	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	2.23e-06	0.00014	CbGpPWpGaD
